BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16214850)

  • 1. Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
    Owen RP; Lagpacan LL; Taylor TR; De La Cruz M; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
    Drug Metab Dispos; 2006 Jan; 34(1):12-5. PubMed ID: 16214850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.
    Gray JH; Mangravite LM; Owen RP; Urban TJ; Chan W; Carlson EJ; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
    Mol Pharmacol; 2004 Mar; 65(3):512-9. PubMed ID: 14978229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).
    Badagnani I; Chan W; Castro RA; Brett CM; Huang CC; Stryke D; Kawamoto M; Johns SJ; Ferrin TE; Carlson EJ; Burchard EG; Giacomini KM
    Pharmacogenomics J; 2005; 5(3):157-65. PubMed ID: 15738947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.
    Owen RP; Gray JH; Taylor TR; Carlson EJ; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
    Pharmacogenet Genomics; 2005 Feb; 15(2):83-90. PubMed ID: 15861032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
    Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
    Nagai K; Nagasawa K; Kihara Y; Okuda H; Fujimoto S
    Int J Pharm; 2007 Mar; 333(1-2):56-61. PubMed ID: 17088032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.
    Mangravite LM; Xiao G; Giacomini KM
    Am J Physiol Renal Physiol; 2003 May; 284(5):F902-10. PubMed ID: 12527552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.
    Markovic I; Segal M; Djuricic B; Redzic Z
    Exp Physiol; 2008 Mar; 93(3):325-33. PubMed ID: 18039975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).
    Urban TJ; Yang C; Lagpacan LL; Brown C; Castro RA; Taylor TR; Huang CC; Stryke D; Johns SJ; Kawamoto M; Carlson EJ; Ferrin TE; Burchard EG; Giacomini KM
    Pharmacogenet Genomics; 2007 Sep; 17(9):773-82. PubMed ID: 17700366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.
    Erdman AR; Mangravite LM; Urban TJ; Lagpacan LL; Castro RA; de la Cruz M; Chan W; Huang CC; Johns SJ; Kawamoto M; Stryke D; Taylor TR; Carlson EJ; Ferrin TE; Brett CM; Burchard EG; Giacomini KM
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F905-12. PubMed ID: 16291576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influx mechanism of 2',3'-dideoxyinosine and uridine at the blood-placenta barrier.
    Sato K; Sai Y; Nishimura T; Chishu T; Shimpo S; Kose N; Nakashima E
    Placenta; 2009 Mar; 30(3):263-9. PubMed ID: 19135251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene.
    Damaraju S; Zhang J; Visser F; Tackaberry T; Dufour J; Smith KM; Slugoski M; Ritzel MW; Baldwin SA; Young JD; Cass CE
    Pharmacogenet Genomics; 2005 Mar; 15(3):173-82. PubMed ID: 15861042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells.
    Robillard KR; Bone DB; Hammond JR
    Microvasc Res; 2008 Apr; 75(3):351-7. PubMed ID: 18048066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.
    Yamamoto T; Kuniki K; Takekuma Y; Hirano T; Iseki K; Sugawara M
    Eur J Pharmacol; 2007 Feb; 557(1):1-8. PubMed ID: 17140564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fluorouridine insensitive 1 (fur1) mutant is defective in equilibrative nucleoside transporter 3 (ENT3), and thus represents an important pyrimidine nucleoside uptake system in Arabidopsis thaliana.
    Traub M; Flörchinger M; Piecuch J; Kunz HH; Weise-Steinmetz A; Deitmer JW; Ekkehard Neuhaus H; Möhlmann T
    Plant J; 2007 Mar; 49(5):855-64. PubMed ID: 17253988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1.
    Chishu T; Sai Y; Nishimura T; Sato K; Kose N; Nakashima E
    Placenta; 2008 May; 29(5):461-7. PubMed ID: 18329095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of equilibrative nucleoside transporter (ENT) 2 to fluorouracil transport in rat placental trophoblast cells.
    Takagi A; Nishimura T; Akashi T; Tomi M; Nakashima E
    Drug Metab Pharmacokinet; 2017 Apr; 32(2):151-156. PubMed ID: 28209435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.